Global Immune Adjuvant Market Research Report 2024

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

The global Immune Adjuvant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Immune Adjuvant is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Immune Adjuvant is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immune Adjuvant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Adjuvant.

Report Scope
The Immune Adjuvant market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Adjuvant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immune Adjuvant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Adjuvant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Adjuvant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

 1 Immune Adjuvant Market Overview
    1.1 Product Overview and Scope of Immune Adjuvant
    1.2 Immune Adjuvant Segment by Type
        1.2.1 Global Immune Adjuvant Market Value Comparison by Type (2024-2030)
        1.2.2 Freund's Adjuvant
        1.2.3 Cytokine Adjuvants
    1.3 Immune Adjuvant Segment by Application
        1.3.1 Global Immune Adjuvant Market Value by Application: (2024-2030)
        1.3.2 Research
        1.3.3 Commercial
    1.4 Global Immune Adjuvant Market Size Estimates and Forecasts
        1.4.1 Global Immune Adjuvant Revenue 2019-2030
        1.4.2 Global Immune Adjuvant Sales 2019-2030
        1.4.3 Global Immune Adjuvant Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Immune Adjuvant Market Competition by Manufacturers
    2.1 Global Immune Adjuvant Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Immune Adjuvant Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Immune Adjuvant Average Price by Manufacturers (2019-2024)
    2.4 Global Immune Adjuvant Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Immune Adjuvant, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Immune Adjuvant, Product Type & Application
    2.7 Immune Adjuvant Market Competitive Situation and Trends
        2.7.1 Immune Adjuvant Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Immune Adjuvant Players Market Share by Revenue
        2.7.3 Global Immune Adjuvant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Immune Adjuvant Retrospective Market Scenario by Region
    3.1 Global Immune Adjuvant Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Immune Adjuvant Global Immune Adjuvant Sales by Region: 2019-2030
        3.2.1 Global Immune Adjuvant Sales by Region: 2019-2024
        3.2.2 Global Immune Adjuvant Sales by Region: 2025-2030
    3.3 Global Immune Adjuvant Global Immune Adjuvant Revenue by Region: 2019-2030
        3.3.1 Global Immune Adjuvant Revenue by Region: 2019-2024
        3.3.2 Global Immune Adjuvant Revenue by Region: 2025-2030
    3.4 North America Immune Adjuvant Market Facts & Figures by Country
        3.4.1 North America Immune Adjuvant Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Immune Adjuvant Sales by Country (2019-2030)
        3.4.3 North America Immune Adjuvant Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Immune Adjuvant Market Facts & Figures by Country
        3.5.1 Europe Immune Adjuvant Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Immune Adjuvant Sales by Country (2019-2030)
        3.5.3 Europe Immune Adjuvant Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Immune Adjuvant Market Facts & Figures by Country
        3.6.1 Asia Pacific Immune Adjuvant Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Immune Adjuvant Sales by Country (2019-2030)
        3.6.3 Asia Pacific Immune Adjuvant Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Immune Adjuvant Market Facts & Figures by Country
        3.7.1 Latin America Immune Adjuvant Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Immune Adjuvant Sales by Country (2019-2030)
        3.7.3 Latin America Immune Adjuvant Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Immune Adjuvant Market Facts & Figures by Country
        3.8.1 Middle East and Africa Immune Adjuvant Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Immune Adjuvant Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Immune Adjuvant Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Immune Adjuvant Sales by Type (2019-2030)
        4.1.1 Global Immune Adjuvant Sales by Type (2019-2024)
        4.1.2 Global Immune Adjuvant Sales by Type (2025-2030)
        4.1.3 Global Immune Adjuvant Sales Market Share by Type (2019-2030)
    4.2 Global Immune Adjuvant Revenue by Type (2019-2030)
        4.2.1 Global Immune Adjuvant Revenue by Type (2019-2024)
        4.2.2 Global Immune Adjuvant Revenue by Type (2025-2030)
        4.2.3 Global Immune Adjuvant Revenue Market Share by Type (2019-2030)
    4.3 Global Immune Adjuvant Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Immune Adjuvant Sales by Application (2019-2030)
        5.1.1 Global Immune Adjuvant Sales by Application (2019-2024)
        5.1.2 Global Immune Adjuvant Sales by Application (2025-2030)
        5.1.3 Global Immune Adjuvant Sales Market Share by Application (2019-2030)
    5.2 Global Immune Adjuvant Revenue by Application (2019-2030)
        5.2.1 Global Immune Adjuvant Revenue by Application (2019-2024)
        5.2.2 Global Immune Adjuvant Revenue by Application (2025-2030)
        5.2.3 Global Immune Adjuvant Revenue Market Share by Application (2019-2030)
    5.3 Global Immune Adjuvant Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 SEPPIC
        6.1.1 SEPPIC Corporation Information
        6.1.2 SEPPIC Description and Business Overview
        6.1.3 SEPPIC Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 SEPPIC Immune Adjuvant Product Portfolio
        6.1.5 SEPPIC Recent Developments/Updates
    6.2 SDA BIO
        6.2.1 SDA BIO Corporation Information
        6.2.2 SDA BIO Description and Business Overview
        6.2.3 SDA BIO Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 SDA BIO Immune Adjuvant Product Portfolio
        6.2.5 SDA BIO Recent Developments/Updates
    6.3 Croda International Plc
        6.3.1 Croda International Plc Corporation Information
        6.3.2 Croda International Plc Description and Business Overview
        6.3.3 Croda International Plc Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Croda International Plc Immune Adjuvant Product Portfolio
        6.3.5 Croda International Plc Recent Developments/Updates
    6.4 SPI Pharma
        6.4.1 SPI Pharma Corporation Information
        6.4.2 SPI Pharma Description and Business Overview
        6.4.3 SPI Pharma Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 SPI Pharma Immune Adjuvant Product Portfolio
        6.4.5 SPI Pharma Recent Developments/Updates
    6.5 Phibro Animal Health Corporation
        6.5.1 Phibro Animal Health Corporation Corporation Information
        6.5.2 Phibro Animal Health Corporation Description and Business Overview
        6.5.3 Phibro Animal Health Corporation Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 Phibro Animal Health Corporation Immune Adjuvant Product Portfolio
        6.5.5 Phibro Animal Health Corporation Recent Developments/Updates
    6.6 Tj Kaiwei
        6.6.1 Tj Kaiwei Corporation Information
        6.6.2 Tj Kaiwei Description and Business Overview
        6.6.3 Tj Kaiwei Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 Tj Kaiwei Immune Adjuvant Product Portfolio
        6.6.5 Tj Kaiwei Recent Developments/Updates
    6.7 Novavax
        6.6.1 Novavax Corporation Information
        6.6.2 Novavax Description and Business Overview
        6.6.3 Novavax Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Novavax Immune Adjuvant Product Portfolio
        6.7.5 Novavax Recent Developments/Updates
    6.8 Zhuoyue
        6.8.1 Zhuoyue Corporation Information
        6.8.2 Zhuoyue Description and Business Overview
        6.8.3 Zhuoyue Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Zhuoyue Immune Adjuvant Product Portfolio
        6.8.5 Zhuoyue Recent Developments/Updates
    6.9 Aphios
        6.9.1 Aphios Corporation Information
        6.9.2 Aphios Description and Business Overview
        6.9.3 Aphios Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 Aphios Immune Adjuvant Product Portfolio
        6.9.5 Aphios Recent Developments/Updates
    6.10 GSK
        6.10.1 GSK Corporation Information
        6.10.2 GSK Description and Business Overview
        6.10.3 GSK Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.10.4 GSK Immune Adjuvant Product Portfolio
        6.10.5 GSK Recent Developments/Updates
    6.11 CSL Limited
        6.11.1 CSL Limited Corporation Information
        6.11.2 CSL Limited Immune Adjuvant Description and Business Overview
        6.11.3 CSL Limited Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.11.4 CSL Limited Immune Adjuvant Product Portfolio
        6.11.5 CSL Limited Recent Developments/Updates
    6.12 Brenntag Biosector
        6.12.1 Brenntag Biosector Corporation Information
        6.12.2 Brenntag Biosector Immune Adjuvant Description and Business Overview
        6.12.3 Brenntag Biosector Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.12.4 Brenntag Biosector Immune Adjuvant Product Portfolio
        6.12.5 Brenntag Biosector Recent Developments/Updates
    6.13 Abace
        6.13.1 Abace Corporation Information
        6.13.2 Abace Immune Adjuvant Description and Business Overview
        6.13.3 Abace Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.13.4 Abace Immune Adjuvant Product Portfolio
        6.13.5 Abace Recent Developments/Updates
    6.14 Avanti Polar Lipids
        6.14.1 Avanti Polar Lipids Corporation Information
        6.14.2 Avanti Polar Lipids Immune Adjuvant Description and Business Overview
        6.14.3 Avanti Polar Lipids Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        6.14.4 Avanti Polar Lipids Immune Adjuvant Product Portfolio
        6.14.5 Avanti Polar Lipids Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Immune Adjuvant Industry Chain Analysis
    7.2 Immune Adjuvant Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Immune Adjuvant Production Mode & Process
    7.4 Immune Adjuvant Sales and Marketing
        7.4.1 Immune Adjuvant Sales Channels
        7.4.2 Immune Adjuvant Distributors
    7.5 Immune Adjuvant Customers

 8 Immune Adjuvant Market Dynamics
    8.1 Immune Adjuvant Industry Trends
    8.2 Immune Adjuvant Market Drivers
    8.3 Immune Adjuvant Market Challenges
    8.4 Immune Adjuvant Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

List of Tables
    Table 1. Global Immune Adjuvant Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Immune Adjuvant Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Immune Adjuvant Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Immune Adjuvant Sales (KG) of Key Manufacturers (2019-2024)
    Table 5. Global Immune Adjuvant Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Immune Adjuvant Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Immune Adjuvant Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Immune Adjuvant Average Price (US$/KG) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Immune Adjuvant, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Immune Adjuvant, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Immune Adjuvant, Product Type & Application
    Table 12. Global Key Manufacturers of Immune Adjuvant, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Immune Adjuvant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Adjuvant as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Immune Adjuvant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Immune Adjuvant Sales by Region (2019-2024) & (KG)
    Table 18. Global Immune Adjuvant Sales Market Share by Region (2019-2024)
    Table 19. Global Immune Adjuvant Sales by Region (2025-2030) & (KG)
    Table 20. Global Immune Adjuvant Sales Market Share by Region (2025-2030)
    Table 21. Global Immune Adjuvant Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Immune Adjuvant Revenue Market Share by Region (2019-2024)
    Table 23. Global Immune Adjuvant Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Immune Adjuvant Revenue Market Share by Region (2025-2030)
    Table 25. North America Immune Adjuvant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Immune Adjuvant Sales by Country (2019-2024) & (KG)
    Table 27. North America Immune Adjuvant Sales by Country (2025-2030) & (KG)
    Table 28. North America Immune Adjuvant Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Immune Adjuvant Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Immune Adjuvant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Immune Adjuvant Sales by Country (2019-2024) & (KG)
    Table 32. Europe Immune Adjuvant Sales by Country (2025-2030) & (KG)
    Table 33. Europe Immune Adjuvant Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Immune Adjuvant Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Immune Adjuvant Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Immune Adjuvant Sales by Region (2019-2024) & (KG)
    Table 37. Asia Pacific Immune Adjuvant Sales by Region (2025-2030) & (KG)
    Table 38. Asia Pacific Immune Adjuvant Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Immune Adjuvant Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Immune Adjuvant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Immune Adjuvant Sales by Country (2019-2024) & (KG)
    Table 42. Latin America Immune Adjuvant Sales by Country (2025-2030) & (KG)
    Table 43. Latin America Immune Adjuvant Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Immune Adjuvant Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Immune Adjuvant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Immune Adjuvant Sales by Country (2019-2024) & (KG)
    Table 47. Middle East & Africa Immune Adjuvant Sales by Country (2025-2030) & (KG)
    Table 48. Middle East & Africa Immune Adjuvant Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Immune Adjuvant Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Immune Adjuvant Sales (KG) by Type (2019-2024)
    Table 51. Global Immune Adjuvant Sales (KG) by Type (2025-2030)
    Table 52. Global Immune Adjuvant Sales Market Share by Type (2019-2024)
    Table 53. Global Immune Adjuvant Sales Market Share by Type (2025-2030)
    Table 54. Global Immune Adjuvant Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Immune Adjuvant Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Immune Adjuvant Revenue Market Share by Type (2019-2024)
    Table 57. Global Immune Adjuvant Revenue Market Share by Type (2025-2030)
    Table 58. Global Immune Adjuvant Price (US$/KG) by Type (2019-2024)
    Table 59. Global Immune Adjuvant Price (US$/KG) by Type (2025-2030)
    Table 60. Global Immune Adjuvant Sales (KG) by Application (2019-2024)
    Table 61. Global Immune Adjuvant Sales (KG) by Application (2025-2030)
    Table 62. Global Immune Adjuvant Sales Market Share by Application (2019-2024)
    Table 63. Global Immune Adjuvant Sales Market Share by Application (2025-2030)
    Table 64. Global Immune Adjuvant Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Immune Adjuvant Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Immune Adjuvant Revenue Market Share by Application (2019-2024)
    Table 67. Global Immune Adjuvant Revenue Market Share by Application (2025-2030)
    Table 68. Global Immune Adjuvant Price (US$/KG) by Application (2019-2024)
    Table 69. Global Immune Adjuvant Price (US$/KG) by Application (2025-2030)
    Table 70. SEPPIC Corporation Information
    Table 71. SEPPIC Description and Business Overview
    Table 72. SEPPIC Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 73. SEPPIC Immune Adjuvant Product
    Table 74. SEPPIC Recent Developments/Updates
    Table 75. SDA BIO Corporation Information
    Table 76. SDA BIO Description and Business Overview
    Table 77. SDA BIO Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 78. SDA BIO Immune Adjuvant Product
    Table 79. SDA BIO Recent Developments/Updates
    Table 80. Croda International Plc Corporation Information
    Table 81. Croda International Plc Description and Business Overview
    Table 82. Croda International Plc Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 83. Croda International Plc Immune Adjuvant Product
    Table 84. Croda International Plc Recent Developments/Updates
    Table 85. SPI Pharma Corporation Information
    Table 86. SPI Pharma Description and Business Overview
    Table 87. SPI Pharma Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 88. SPI Pharma Immune Adjuvant Product
    Table 89. SPI Pharma Recent Developments/Updates
    Table 90. Phibro Animal Health Corporation Corporation Information
    Table 91. Phibro Animal Health Corporation Description and Business Overview
    Table 92. Phibro Animal Health Corporation Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 93. Phibro Animal Health Corporation Immune Adjuvant Product
    Table 94. Phibro Animal Health Corporation Recent Developments/Updates
    Table 95. Tj Kaiwei Corporation Information
    Table 96. Tj Kaiwei Description and Business Overview
    Table 97. Tj Kaiwei Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 98. Tj Kaiwei Immune Adjuvant Product
    Table 99. Tj Kaiwei Recent Developments/Updates
    Table 100. Novavax Corporation Information
    Table 101. Novavax Description and Business Overview
    Table 102. Novavax Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 103. Novavax Immune Adjuvant Product
    Table 104. Novavax Recent Developments/Updates
    Table 105. Zhuoyue Corporation Information
    Table 106. Zhuoyue Description and Business Overview
    Table 107. Zhuoyue Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 108. Zhuoyue Immune Adjuvant Product
    Table 109. Zhuoyue Recent Developments/Updates
    Table 110. Aphios Corporation Information
    Table 111. Aphios Description and Business Overview
    Table 112. Aphios Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 113. Aphios Immune Adjuvant Product
    Table 114. Aphios Recent Developments/Updates
    Table 115. GSK Corporation Information
    Table 116. GSK Description and Business Overview
    Table 117. GSK Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 118. GSK Immune Adjuvant Product
    Table 119. GSK Recent Developments/Updates
    Table 120. CSL Limited Corporation Information
    Table 121. CSL Limited Description and Business Overview
    Table 122. CSL Limited Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 123. CSL Limited Immune Adjuvant Product
    Table 124. CSL Limited Recent Developments/Updates
    Table 125. Brenntag Biosector Corporation Information
    Table 126. Brenntag Biosector Description and Business Overview
    Table 127. Brenntag Biosector Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 128. Brenntag Biosector Immune Adjuvant Product
    Table 129. Brenntag Biosector Recent Developments/Updates
    Table 130. Abace Corporation Information
    Table 131. Abace Description and Business Overview
    Table 132. Abace Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 133. Abace Immune Adjuvant Product
    Table 134. Abace Recent Developments/Updates
    Table 135. Avanti Polar Lipids Corporation Information
    Table 136. Avanti Polar Lipids Description and Business Overview
    Table 137. Avanti Polar Lipids Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 138. Avanti Polar Lipids Immune Adjuvant Product
    Table 139. Avanti Polar Lipids Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Immune Adjuvant Distributors List
    Table 143. Immune Adjuvant Customers List
    Table 144. Immune Adjuvant Market Trends
    Table 145. Immune Adjuvant Market Drivers
    Table 146. Immune Adjuvant Market Challenges
    Table 147. Immune Adjuvant Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Immune Adjuvant
    Figure 2. Global Immune Adjuvant Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Immune Adjuvant Market Share by Type in 2023 & 2030
    Figure 4. Freund's Adjuvant Product Picture
    Figure 5. Cytokine Adjuvants Product Picture
    Figure 6. Global Immune Adjuvant Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Immune Adjuvant Market Share by Application in 2023 & 2030
    Figure 8. Research
    Figure 9. Commercial
    Figure 10. Global Immune Adjuvant Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Immune Adjuvant Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Immune Adjuvant Sales (2019-2030) & (KG)
    Figure 13. Global Immune Adjuvant Average Price (US$/KG) & (2019-2030)
    Figure 14. Immune Adjuvant Report Years Considered
    Figure 15. Immune Adjuvant Sales Share by Manufacturers in 2023
    Figure 16. Global Immune Adjuvant Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Immune Adjuvant Players: Market Share by Revenue in 2023
    Figure 18. Immune Adjuvant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Immune Adjuvant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Immune Adjuvant Sales Market Share by Country (2019-2030)
    Figure 21. North America Immune Adjuvant Revenue Market Share by Country (2019-2030)
    Figure 22. United States Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Immune Adjuvant Sales Market Share by Country (2019-2030)
    Figure 25. Europe Immune Adjuvant Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Immune Adjuvant Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Immune Adjuvant Revenue Market Share by Region (2019-2030)
    Figure 33. China Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Immune Adjuvant Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Immune Adjuvant Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Immune Adjuvant Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Immune Adjuvant Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Immune Adjuvant Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Immune Adjuvant by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Immune Adjuvant by Type (2019-2030)
    Figure 54. Global Immune Adjuvant Price (US$/KG) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Immune Adjuvant by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Immune Adjuvant by Application (2019-2030)
    Figure 57. Global Immune Adjuvant Price (US$/KG) by Application (2019-2030)
    Figure 58. Immune Adjuvant Value Chain
    Figure 59. Immune Adjuvant Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

The global Immune Adjuvant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Immune Adjuvant is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Immune Adjuvant is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immune Adjuvant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Adjuvant.

Report Scope
The Immune Adjuvant market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Adjuvant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immune Adjuvant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Adjuvant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Adjuvant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.